Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mendell HeliumLSE:MDH +7.29% EBITDA Margin % is -400.00% as of Dec. 2025. Among 958 Drug Manufacturers companies, Mendell Helium ranks worse than 96.14% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mendell Helium's EBITDA for the
six
months ended in Dec. 2025 was £-0.08 Mil. Mendell Helium's Revenue for the
six
months ended in Dec. 2025 was £0.02 Mil. Therefore, Mendell Helium's EBITDA margin for the quarter that ended in Dec. 2025 was -400.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Mendell Helium EBITDA Margin % Related Terms
Mendell Helium EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Mendell Helium's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mendell Helium EBITDA Margin % Chart
Mendell Helium Annual Data
Trend
Jun24
EBITDA Margin %
-16,800.00
Mendell Helium Semi-Annual Data
Jun24
Dec24
Jun25
Dec25
EBITDA Margin %
0.00
-76.78
-880.00
-400.00
LSE:MDH vs ZTS, UTHR, VTRS: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Mendell Helium's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mendell Helium EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mendell Helium's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Mendell Helium's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mendell Helium (LSE:MDH) has a EBITDA Margin % of -400.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mendell Helium and its competitors. According to the industry distribution chart, Mendell Helium ranks #921 out of 958 companies in the Drug Manufacturers industry, placing it in the top 96.1%.
Is Mendell Helium's EBITDA Margin % too high?
Mendell Helium's current EBITDA Margin % is -400.00%. Based on the distribution chart, Mendell Helium ranks #921 out of 958 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Mendell Helium's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mendell Helium ranks #921 out of 958 companies for EBITDA Margin %. This places Mendell Helium in the lower half of its industry. The industry median EBITDA Margin % is 12.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.11, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Mendell Helium and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mendell Helium's current EBITDA Margin % is -400.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mendell Helium stock overvalued right now?
Mendell Helium (LSE:MDH) has a current EBITDA Margin % of -400.00%. The current EBITDA Margin % is -400.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Mendell Helium (LSE:MDH), the current EBITDA Margin % is -400.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mendell Helium PLC is a helium production and exploration company. The company operates in Kansas. The project portfolio of the company includes Fort Dodge, Hugoton, and Bitcoin Treasury.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MDH has been successfully added to your 
